Financial Services
Abrdn Healthcare Investors(HQH)
Live Price
Offline$19.37
+1.73% today
1Y Change
+32.13%
Window
Jun 25, 2025 → Jun 23, 2026
- Market Cap
- $1.14B
- Revenue Growth
- +826.8%
- EPS Growth
- -48.2%
- Dividend Yield
- 11.3%
Coverage: 249 bars · Jun 25, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Abrdn Healthcare Investors (HQH) is a Financial Services stock with a market cap of $1.14B and listed on NYSE. The stock last traded around $19.37 and up 32.1% across the available one-year price window (Jun 25, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +826.8%, EPS growth of -48.2%, a dividend yield of 11.3%. What stands out right now is revenue +826.8%, EPS -48.2%, free cash flow 0.0% with operating margin 770.3% and ROIC 15.8%. The dividend matters to the case here, with a current yield around 11.3%. Valuation already assumes a fairly strong business story at P/E 4.2 and price/sales 50.5. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines HQH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+826.8% vs +3.4% peer median
Operating Margin
Above sector median
+770.3% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at +826.8% and EPS is at -48.2%, with operating margin around 770.3%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 11.3%, which matters if the thesis depends on income as much as growth.
Benchmark Edge
HQH vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HQH
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HQH Max Drawdown
-15.69%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HQH and SPY.
Company Overview
Abrdn Healthcare Investors
New York Stock Exchange
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
- Leadership
- Daniel R. Omstead
- IPO Date
- Apr 23, 1987
- Street Address
- 100 Federal Street
- Mailing
- Philadelphia, PA, 02110
- Region
- Philadelphia, PA, US
- Reporting Currency
- USD
- Investor Line
- 215 405 5700
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 4.2
- EV/EBITDA
- 6.5
- Price/Sales
- 50.5
- Price/Book
- 1.0
Growth
- Revenue
- +826.8%
- EPS
- -48.2%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 77.2%
- Operating Margin
- 770.3%
- Net Margin
- 1150.1%
- ROE
- 24.0%
- ROIC
- 15.8%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.04
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.